glp-1 jumpstart guide Your First Month on a Medication 💡Read the full guide here:

Glucagon-like peptide1 receptor agonists (GLP-1RAs) have emerged as a transformative class of therapies initially developed for glycemic control in type2 diabetes mellitus

Rheumatology insights & real results.

These GLP-1 drugs are ubiquitous in life - helping people manage diabetes and, hopefully, reducing their risk

Background In idiopathic intracranial hypertension (IIH), sustained weight loss is the main pillar in modifying disease course, whereby glucagon-like peptide-1 receptor agonists (GLP-1-RAs) could present an attractive treatment option

These are often labeled for research use only but are being illegally used by consumers for weight loss without medical supervision

Discover how medications like Ozempic and Wegovy may reduce joint symptoms through weight loss and potential anti-inflammatory effects